Company News

How VarSome Clinical powered Gencell to become Colombia’s first CAP-accredited molecular genetics lab

Lyndsey Fletcher — Thu, 15 Oct 2026 13:34:18 GMT

In a historic milestone for Latin American healthcare, our partner Gencell LATAM has officially become the first diagnostic laboratory in Colombia to achieve prestigious CAP (College of American Pathologists) accreditation in molecular biology and genetics. This benchmark recognition underscores Gencell’s relentless dedication to delivering world-class analytical quality, empowering physicians, health insurers, and patients across the region with clinical results backed by the highest international standards.

Saphetor Appoints Gene X-Press as Official Distributor for VarSome in Chile

xanthippi.papakonstanti@saphetor.com (Xanthippi Papakonstanti) — Thu, 15 Oct 2026 12:38:26 GMT

Lausanne, Switzerland, October 15th 2026 - Saphetor, developer of the VarSome suite, is pleased to announce the appointment of Gene X-Press as the official distributor for VarSome in Chile.

The agreement expands local access to VarSome’s genomic variant analysis and interpretation solutions, providing laboratories, researchers, and genomics professionals in Chile with dedicated commercial and technical support through Gene X-Press.

Expanding population frequency data in VarSome: Introducing Korean and Japanese frequency databases

Lyndsey Fletcher — Fri, 07 Aug 2026 11:02:56 GMT

Accurate variant interpretation depends on access to representative population frequency data. In VarSome v13.18, we’ve expanded our population frequency resources through the integration of KRIBB KOVA and ToMMo jMorp, which offer population allele frequency data from the Korean and Japanese populations, respectively. These datasets help laboratories interpret variants with greater confidence by offering ancestry-specific context, supporting more equitable genomic analysis for increasingly diverse populations.

World Population Day 2026

Lyndsey Fletcher — Fri, 10 Jul 2026 08:41:07 GMT

In recent decades, advances in technology, healthcare, sanitation, and nutrition have led to a dramatic increase in human life expectancy. Many diseases that once claimed millions of lives are now treatable or even entirely preventable, and improved living standards have contributed to increasing longevity. But with longer lifespans comes a new challenge: a rapidly aging population.

Reclassification of VUS with VarSome

Lyndsey Fletcher — Fri, 19 Jun 2026 12:37:56 GMT

Variants of uncertain significance (VUS) are the most frequent outcome in germline genetic testing, with almost 30% of patients receiving only VUS results. This delays clinical decisions and forces manual review, complicating the interpretation of rare alleles.

Overlap with Known Structural Variants in VarSome Clinical

jason.armstrong@varsome.com (Jason Armstrong) — Mon, 16 Mar 2026 13:02:59 GMT

VarSome Clinical now includes an Overlap with Known SVs column within the Structural Variant Table. This new feature provides an immediate view of how a copy number variant overlaps with previously reported SVs, supporting faster and more consistent interpretation.

RNA Fusion Annotation in VarSome Clinical

jason.armstrong@varsome.com (Jason Armstrong) — Mon, 16 Mar 2026 09:09:05 GMT

Our fusion annotation solution is built for routine somatic oncology workflows. Upload TSV or CSV files from widely used fusion callers across amplicon and hybrid capture assays, and review annotated fusion events in a structured format. RNA fusion analysis can be performed on its own or alongside DNA variants in single-sample or tumour-normal analysis.

Saphetor Announces Appointment of Esteban Czwan as Chief Commercial Officer

jason.armstrong@varsome.com (Jason Armstrong) — Wed, 10 Dec 2025 08:40:20 GMT

Lausanne, Switzerland, 10th December 2025 - Saphetor SA, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Esteban Czwan as Chief Commercial Officer, effective 5th December 2025. Esteban will be responsible for global commercial strategy and activity as Saphetor continues its expansion into key markets.

MolecularDB: A Unified Source for Genomic Data Analysis

jason.armstrong@varsome.com (Jason Armstrong) — Wed, 19 Nov 2025 08:59:52 GMT

Updated 16th March 2026

In clinical genomics, you are often confronted with fragmented, siloed data sources in different formats and the constant challenge of bringing together disparate sets of evidence. To provide you with a comprehensive and integrated solution, we built VarSome's MolecularDB.

VarSome Picks: Algorithmic Prioritization That Thinks Like a Clinician

jason.armstrong@varsome.com (Jason Armstrong) — Thu, 13 Nov 2025 12:07:19 GMT